# Neurocrine Biosciences Inc. (NBIX) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $2.86B |
| 2024 | $2.36B |
| 2023 | $1.89B |
| 2022 | $1.49B |
| 2021 | $1.13B |
| 2020 | $1.05B |
| 2019 | $788M |
| 2018 | $451M |
| 2017 | $162M |
| 2016 | $15M |
| 2015 | $20M |
| 2014 | — |
| 2013 | $3M |
| 2012 | $53M |
| 2011 | $77M |
| 2010 | $34M |
| 2009 | $3M |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $815M |
| 2025-09-30 | $795M |
| 2025-06-30 | $688M |
| 2025-03-31 | $573M |
| 2024-09-30 | $622M |
| 2024-06-30 | $590M |
| 2024-03-31 | $515M |
| 2023-09-30 | $499M |
| 2023-06-30 | $453M |
| 2023-03-31 | $420M |
| 2022-09-30 | $388M |
| 2022-06-30 | $378M |
| 2022-03-31 | $311M |
| 2021-09-30 | $296M |
| 2021-06-30 | $289M |
| 2021-03-31 | $237M |
| 2020-09-30 | $259M |
| 2020-06-30 | $302M |
| 2020-03-31 | $237M |
| 2019-09-30 | $222M |
| 2019-06-30 | $184M |
| 2019-03-31 | $138M |
| 2018-09-30 | $152M |
| 2018-06-30 | $97M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/NBIX/revenue)